LOWER SERUM FSH LEVELS IN RESPONSE TO IV RECOMBINANT FSH IN OBESE WOMEN IS NOT EXPLAINED BY GNRH ANTAGONIST (CETRORELIX) PHARMACODYNAMICS

Authors :: Michael F. Wempe
Andrew P. Bradford
Thanh Ha Luu
Nne-Omoji Nwobodo
Alex J. Polotsky
Luke Wittenburg
Katherine Kuhn
Source :: Fertility and Sterility. 114:e8
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: medicine.medical_specialty
Serum fsh
business.industry
GnRH Antagonist
Obstetrics and Gynecology
Recombinant fsh
Endocrinology
Reproductive Medicine
Cetrorelix
Internal medicine
Pharmacodynamics
Medicine
business
medicine.drug

Full Text Access

Tools